2 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow Plasmablastic Lymphoma: new trials by email Literature Review of Plasmablastic Lymphoma trials Research Report on Plasmablastic Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas Cyclophosphamide, Doxorubicin Hydrochloride, Etoposide - AIDS-Related Plasmablastic Lymphoma, AIDS-Related Primary Effusion Lymphoma | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 107 | 2010-10-06 | 2023-11-21 |
| Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma EPOCH-R, EPOCH-RR - Burkitt Lymphoma, Diffuse Large B-cell Lymphoma, c-MYC Positive | Phase 2 | Completed | National Cancer Institute (NCI) | 194 | 2010-03-25 | 2023-04-27 |
HIV Infections (2) · Lymphoma, Large B-Cell, Diffuse (2) · Burkitt Lymphoma (1) · HIV Seropositivity (1) · Lymphoma, Follicular (1) · Lymphoma, Primary Effusion (1)
Blood-Borne Infections (2) · Communicable Diseases (2) · Genital Diseases (2) · Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Immunologic Deficiency Syndromes (2) · Immunoproliferative Disorders (2) · Infections (2) · Lentivirus Infections (2) · Lymphatic Diseases (2) · Lymphoma (2) · Lymphoma, B-Cell (2) · Lymphoma, Non-Hodgkin (2) · Lymphoproliferative Disorders (2) · Neoplasms (2)
Cyclophosphamide (2) · Doxorubicin (2) · Etoposide (2) · Prednisone (2) · Rituximab (2) · Vincristine (2) · CT-P10 (1) · Vorinostat (1) · deltacortene (1) · prednylidene (1)
National Cancer Institute (NCI) (2)
United States (2)
Juan C Ramos (1) · Mark J Roschewski, M.D. (1)
PMID 30501868, PMID 32430507, PMID 32453640
UM1CA121947 (1)